Tuberculosis (TB) and HIV Coinfection
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 11772
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to present the most recent advances in the diagnosis, treatment and research of HIV and Mycobacterium Tuberculosis co-infection. The Special Issue will attend to a variety of topics that include, but are not limited to, the following: 1) the prevalence of tuberculosis among HIV-infected/AIDS patients; 2) technologies and strategies employed in the screening and diagnosis of tuberculosis in HIV-infected/AIDS patients; 3) the treatment and outcome of tuberculosis in HIV-infected/AIDS patients, particularly with regard to clinical research that is related to the WHO’s recommended short-term treatment strategy for drug-sensitive tuberculosis in HIV-positive patients; 4) antiviral treatment and treatment outcomes in HIV-positive patients with tuberculosis; 5) the interaction between anti-HIV drugs and anti-tuberculosis drugs; 6) the pathogenesis, intervention and prognosis of tuberculosis-associated immune reconstitution inflammation; and 7) the long-term prognosis and management mode of HIV-infected/AIDS patients with tuberculosis. This Special Issue focuses on clinical research, particularly multi-center clinical studies, but related basic research is also greatly welcome.
Dr. Yinzhong Shen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tuberculosis
- HIV infection
- epidemiology
- diagnosis
- treatment
- antiretroviral therapy
- immune reconstitution inflammatory syndrome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.